🇺🇸 FDA
Patent

US 7547794

Compositions useful as inhibitors of protein kinases

granted A61PA61P11/06A61P13/12

Quick answer

US patent 7547794 (Compositions useful as inhibitors of protein kinases) held by Vertex Pharmaceuticals Incorporated expires Mon Jun 11 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Jun 16 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 11 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61P, A61P11/06, A61P13/12, A61P17/14, A61P19/00